Skip to main content
Clinical Trials/NCT04440930
NCT04440930CompletedNot Applicable

Can White Tea Prevent Oral Mucositis in Patients Receiving Neoadjuvant or Adjuvant Treatment With Paclitaxel for Breast Cancer? A Randomized Trial

Vejle Hospital1 site in 1 country88 target enrollmentStarted: September 2, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
88
Locations
1
Primary Endpoint
Incidence of oral mucositis grade 2 or higher as measured by the Revised Oral Assessment Guide.

Study Overview

Brief Summary

The aim of this study is to determine the effectiveness of mouthwash with white tea in the prevention of paclitaxel induced oral mucositis in women with breast cancer.

Detailed Description

Oral mucositis is a common side effect from paclitaxel treatment. It can be very painful and compromise nutrition and oral hygiene, and it may increase the risk of infection. Although oral mucositis is a common side effect to chemotherapy, no available treatment is yet available that can effectively prevent or treat oral mucositis.

Based on the knowledge that white tea has anti-inflammatory, anti-oxidant and anti-microbial effect, the current study aims to assess the effect of mouth wash with white tea on paclitaxel induced oral mucositis in women with breast cancer.

This study is a phase II randomized controlled trial in which eligible patients will be allocated to a control group (CG) and a study group (SG). The CG will use salt water with soda for mouthwash eight to ten times a day and the SG will use white tea for mouthwash five to six times a day.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Woman with breast cancer
  • •Planned neoadjuvant or adjuvant paclitaxel treatment
  • •Age ≥ 18 years
  • •Understand and speak Danish
  • •Written and orally informed consent

Exclusion Criteria

  • •Palliative treatment with paclitaxel

Arms & Interventions

White tea

Experimental

Intervention: White tea (Other)

Salt water with soda

Active Comparator

Intervention: Salt water with soda (Other)

Outcomes

Primary Outcomes

Incidence of oral mucositis grade 2 or higher as measured by the Revised Oral Assessment Guide.

Time Frame: up to nine weeks

Nine categories are included in the Revised Oral Assessment Guide tool: voice, lips, mucous, tongue, gums, teeth, saliva, denture and swallowing. Each category is described and rated according to a score of 1 (healthy) to 3 (severe problems).

Secondary Outcomes

  • Pain intensity in the oral cavity as measured on the Numeric Rating Scale (NRS).(Once a week over a period of nine weeks)
  • Date of onset of oral mucositis grade 2 or higher as measured by Revised Oral Assessment Guide.(Once a week until oral mucositis occurs up to nine weeks)
  • Frequency of daily tooth brushings(once a week over a period of nine weeks)
  • Frequency of daily mouthwashes(once a week over a period of nine weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials